Patent ID: 11971411
Assignee: DANA-FARBER CANCER INSTITUTE, INC.
Field: Measurement (Instruments)
Classification: CPC G  C | IPC C  G

Claim 6:
7. A method of treating prostate cancer in a subject, comprising:
a) providing a biological sample from the subject,
b) measuring the expression level of a set of biomarkers consisting of ZFP36 and PTEN in the sample,
c) detecting decreased expression levels of the set of biomarkers consisting of ZFP36 and PTEN in the sample as compared to the expression level of ZFP36 and PTEN in control subjects without prostate cancer recurrence, and
d) treating the subject from step c) with one or more therapies selected from surgical castration, androgen deprivation therapy, a radiation therapy, an ablation therapy, a chemotherapy, a targeted therapy, or an immunotherapy.